Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle--a comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame.

The substantial transformation of the angiotensin II receptor antagonist valsartan to the transformation product 2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-carboxylic acid (referred to as valsartan acid) during the activated sludge process was demonstrated in the literature and confirmed in the here presented study. However, there was a severe lack of knowledge regarding the occurrence and fate of this compound in surface water and its behavior during drinking water treatment. In this work a comparative study on the occurrence and persistency of valsartan acid, three frequently used β-blockers (metoprolol, atenolol, and sotalol), atenolol acid (one significant transformation product of atenolol and metoprolol), and the two widely distributed persistent anthropogenic wastewater indicators carbamazepine and acesulfame in raw sewage, treated wastewater, surface water, groundwater, and tap water is presented. Median concentrations of valsartan acid in the analyzed matrices were 101, 1,310, 69, <1.0, and 65 ng L(-1), respectively. Treated effluents from wastewater treatment plants were confirmed as significant source. Regarding concentration levels of pharmaceutical residues in surface waters valsartan acid was found just as relevant as the analyzed β-blockers and the anticonvulsant carbamazepine. Regarding its persistency in surface waters it was comparable to carbamazepine and acesulfame. Furthermore, removal of valsartan acid during bank filtration was poor, which demonstrated the relevance of this compound for drinking water suppliers. Regarding drinking water treatment (Muelheim Process) the compound was resistant to ozonation but effectively eliminated (≥90%) by subsequent activated carbon filtration. However, without applying activated carbon filtration the compound may enter the drinking water distribution system as it was demonstrated for Berlin tap water.

[1]  M. Sauter,et al.  Occurrence and spatial distribution of organic micro-pollutants in a complex hydrogeological karst system during low flow and high flow periods, results of a two-year study. , 2013, The Science of the total environment.

[2]  T. Poiger,et al.  Ubiquitous occurrence of the artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of domestic wastewater in groundwater. , 2009, Environmental science & technology.

[3]  T. T. ter Laak,et al.  Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. , 2013, The Science of the total environment.

[4]  T. Licha,et al.  The challenge of sample-stabilisation in the era of multi-residue analytical methods: a practical guideline for the stabilisation of 46 organic micropollutants in aqueous samples. , 2013, The Science of the total environment.

[5]  J. V. Sancho,et al.  Multi-class determination of personal care products and pharmaceuticals in environmental and wastewater samples by ultra-high performance liquid-chromatography-tandem mass spectrometry. , 2012, Talanta.

[6]  M. Sauter,et al.  Caffeine as an indicator for the quantification of untreated wastewater in karst systems. , 2012, Water research.

[7]  G. Amy,et al.  Occurrence and fate of bulk organic matter and pharmaceutically active compounds in managed aquifer recharge: a review. , 2011, Water Research.

[8]  Christian Zwiener,et al.  Tracking artificial sweeteners and pharmaceuticals introduced into urban groundwater by leaking sewer networks. , 2012, The Science of the total environment.

[9]  Christa S. McArdell,et al.  Multiresidue analysis of 88 polar organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase extraction coupled to high performance liquid chromatography-tandem mass spectrometry. , 2012, Journal of chromatography. A.

[10]  M. Sauter,et al.  Identification of the attenuation potential of a karst aquifer by an artificial dualtracer experiment with caffeine. , 2012, Water research.

[11]  F. Lange,et al.  Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT) , 2009, Analytical and bioanalytical chemistry.

[12]  X. Sanchez‐Vila,et al.  Fate of β-blockers in aquifer material under nitrate reducing conditions: batch experiments. , 2012, Chemosphere.

[13]  D. Aga,et al.  Micropollutant fate in wastewater treatment: redefining "removal". , 2012, Environmental science & technology.

[14]  Thomas Heberer,et al.  Tracking persistent pharmaceutical residues from municipal sewage to drinking water , 2002 .

[15]  M. Sauter,et al.  A case study on the correlation of micro-contaminants and potassium in the Leine River (Germany) , 2011 .

[16]  Peter A Vanrolleghem,et al.  Xenobiotic removal efficiencies in wastewater treatment plants: residence time distributions as a guiding principle for sampling strategies. , 2011, Water research.

[17]  S. Pérez,et al.  Evidence for the microbially mediated abiotic formation of reversible and non-reversible sulfamethoxazole transformation products during denitrification. , 2012, Water research.

[18]  F. Lange,et al.  Performance of conventional multi-barrier drinking water treatment plants for the removal of four artificial sweeteners. , 2010, Water research.

[19]  M. Schaffer,et al.  Sorption influenced transport of ionizable pharmaceuticals onto a natural sandy aquifer sediment at different pH. , 2012, Chemosphere.

[20]  J. Lazorchak,et al.  Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. , 2008, Analytical chemistry.

[21]  A. Gómez-Caballero,et al.  Multi-residue analysis of pharmaceutical compounds in wastewaters by dual solid-phase microextraction coupled to liquid chromatography electrospray ionization ion trap mass spectrometry. , 2010, Journal of chromatography. A.

[22]  O. Lev,et al.  Correlation of six anthropogenic markers in wastewater, surface water, bank filtrate, and soil aquifer treatment. , 2011, Journal of environmental monitoring : JEM.

[23]  Barbara Kasprzyk-Hordern,et al.  The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. , 2008, Water research.

[24]  Richard Grace,et al.  Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary. , 2013, Environment international.

[25]  L. Coiffard,et al.  Photodegradation kinetics of acesulfame-K solutions under UV light: effect of pH , 1999 .

[26]  S. Snyder,et al.  Toxicological relevance of pharmaceuticals in drinking water. , 2010, Environmental science & technology.

[27]  Kaoru Saito,et al.  Metabolic Fate of Losartan, a New Angiotensin II Receptor Antagonist (1) : Absorption, Distribution, Metabolism and Excretion after Single Administration in Rats , 1995 .

[28]  Gaurab Bhardwaj.  How the antihypertensive losartan was discovered , 2006, Expert opinion on drug discovery.

[29]  Christoph Ort,et al.  Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. , 2010, Environmental science & technology.

[30]  T. Poiger,et al.  Hydrophilic anthropogenic markers for quantification of wastewater contamination in ground‐and surface WATERS , 2009, Environmental toxicology and chemistry.

[31]  T. Ternes,et al.  The challenge of analyzing beta-blocker drugs in sludge and wastewater , 2010, Analytical and bioanalytical chemistry.

[32]  Francesc Ventura,et al.  Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. , 2011, Water research.

[33]  D. A. Barry,et al.  Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon? , 2013, The Science of the total environment.

[34]  Silvia Berkner,et al.  Biodegradability and transformation of human pharmaceutical active ingredients in environmentally relevant test systems , 2013, Environmental Science and Pollution Research.

[35]  Tobias Licha,et al.  Development of a multi-residue analytical method, based on liquid chromatography-tandem mass spectrometry, for the simultaneous determination of 46 micro-contaminants in aqueous samples. , 2010, Journal of chromatography. A.

[36]  Heinz Singer,et al.  A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. , 2010, Journal of environmental monitoring : JEM.

[37]  Heinz Singer,et al.  High-throughput identification of microbial transformation products of organic micropollutants. , 2010, Environmental science & technology.

[38]  Uwe Kunkel,et al.  Fate of pharmaceuticals in rivers: Deriving a benchmark dataset at favorable attenuation conditions. , 2012, Water research.

[39]  Frank Sacher,et al.  Removal of pharmaceuticals during drinking water treatment. , 2002, Environmental science & technology.

[40]  F. Lange,et al.  Artificial sweeteners—a recently recognized class of emerging environmental contaminants: a review , 2012, Analytical and Bioanalytical Chemistry.

[41]  J. Choubert,et al.  Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. , 2010, The Science of the total environment.

[42]  N Kreuzinger,et al.  Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. , 2004, Water research.